Intraocular lens
Latest Santen Pharmaceutical Co., Ltd. Patents:
- Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor
- AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG
- Medicament for preventing and/or treating dry eye
- Agent for treating or preventing glaucoma including a sulfonamide compound and another drug
- Therapeutic agent for meibomian dysfunction
Description
The broken line showings of
Claims
The ornamental design for an intraocular lens, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
5217490 | June 8, 1993 | Sayano et al. |
5217491 | June 8, 1993 | Vanderbilt |
5326506 | July 5, 1994 | Vanderbilt |
5716403 | February 10, 1998 | Tran et al. |
5725574 | March 10, 1998 | Nguyen |
D395512 | June 23, 1998 | Korenfeld |
5840219 | November 24, 1998 | Nguyen |
6488709 | December 3, 2002 | Barrett |
6969403 | November 29, 2005 | Peng et al. |
7615073 | November 10, 2009 | Deacon et al. |
7621949 | November 24, 2009 | Deacon et al. |
7794497 | September 14, 2010 | Brady et al. |
7837730 | November 23, 2010 | Cumming et al. |
- U.S. Appl. No. 12/954,424, filed Nov. 24, 2010, Doraiswamy et al.
- U.S. Appl. No. 12/955,654, filed Nov. 29, 2010, Doraiswamy et al.
Patent History
Patent number: D689611
Type: Grant
Filed: Sep 6, 2011
Date of Patent: Sep 10, 2013
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-Shi, Osaka)
Inventors: Anand Doraiswamy (Goleta, CA), Jensen Buck (Goleta, CA), Daniel Hamilton (Emeryville, CA)
Primary Examiner: Randall Gholson
Application Number: 29/401,066
Type: Grant
Filed: Sep 6, 2011
Date of Patent: Sep 10, 2013
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-Shi, Osaka)
Inventors: Anand Doraiswamy (Goleta, CA), Jensen Buck (Goleta, CA), Daniel Hamilton (Emeryville, CA)
Primary Examiner: Randall Gholson
Application Number: 29/401,066
Classifications
Current U.S. Class:
Ocular (D24/157)